Bioneer and Chr. Hansen have entered into collaboration on a project aimed at demonstrating the probiotic effects of lactic acid bacteria. The Danish Ministry of Food, Agriculture and Fisheries is supporting the project with an Innovation grant of 1.7 mil
MP-Biomedicals (formerly ICN Biomedicals) is dedicated to providing quality Life Science & research products as well as medical diagnostics. Two major acquisitions of MP-Biomedicals are Genelabs Diagnostics & Q-BIOgene.
With a team of over 150 staff, BioFocus offers fully integrated, multidisciplinary chemistry and biology expertise for pre-clinical drug discovery. These skills, combined with proprietary assay and design technologies provide accelerated partnered program
Caprion Pharmaceuticals Inc. is a biotechnology company applying proteomics – the study of the nature and function of proteins – to accelerate the diagnosis and treatment of...
Galapagos is a discovery company focused on the identification of disease modifying drug targets by functionally screening human disease models and the subsequent progression of these targets into drug discovery
Cenix BioScience is a specialist in advanced, cell-based applications of RNA interference (RNAi), a breakthrough gene silencing technology for the discovery and functional characterization of novel therapeutic targets and drug candidates.
Services: Biomarker & target discovery, validation, analysis of food and ingredients, absolute quantification of proteins ans peptides, sequencing and characterization of proteins and antibodies (CDR), 2DE and LC-MS based proteomics studies, pharmacokinet
Compugen designs, develops, and markets proprietary bioinformatics solutions that enhance the ability of pharmaceutical and biotech teams to extract meaningful information from genomic and protein sequence data, and accelerate the discovery of new drug le
EGeen is a transatlantic CRO whose key business focus is to advance the drug development of biotech and pharmaceutical clients via expeditious and high quality yet cost-effective clinical trials.
G2 has leading edge capabilities in target discovery and validation, and antibody discovery, production and development. Its patent suite covers targets and therapies in inflammation and cancer, and its lead programme, an antibody therapeutic for Rheumato
Amsterdam Molecular Therapeutics (AMT) is focused on the development of virus-based therapeutics. The lead products of AMT are an adeno-associated virus (AAV)-based gene therapy for treatment of lipoprotein lipase deficiency and a retroviral product for i
Bionomics is focused on the discovery of genes associated with epilepsy, angiogenesis and breast cancer, which are diseases or disease processes that have an unmet therapeutic need and which represent large potential markets for drugs and diagnostics.
Ingenuity Systems enable researchers to model, analyze and understand complex biological systems foundational to human health and disease. The Ingenuity products include pathways analysis software...
Odyssey Thera Inc. is a drug discovery company that has developed a global cellular pharmacology strategy for the identification of safe and effective medicines for a wide spectrum of human diseases
Welcome to American Drug Discovery, the journal dedicated entirely to the subject of drug discovery. American Drug Discovery is a bi-monthly publication for the pharmaceutical and biotech industries throughout North America.
